Literature DB >> 1712492

CD5+ B lymphocytes.

M T Kasaian1, H Ikematsu, P Casali.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1712492     DOI： 10.3181/00379727-197-43250

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  5 in total

1.  Identification and analysis of a novel human surface CD5- B lymphocyte subset producing natural antibodies.

Authors:  M T Kasaian; H Ikematsu; P Casali
Journal:  J Immunol       Date:  1992-05-01       Impact factor: 5.422

2.  Complete sequence of the genes encoding the VH and VL regions of low- and high-affinity monoclonal IgM and IgA1 rheumatoid factors produced by CD5+ B cells from a rheumatoid arthritis patient.

Authors:  N Harindranath; I S Goldfarb; H Ikematsu; S E Burastero; R L Wilder; A L Notkins; P Casali
Journal:  Int Immunol       Date:  1991-09       Impact factor: 4.823

3.  Human rheumatoid B-1a (CD5+ B) cells make somatically hypermutated high affinity IgM rheumatoid factors.

Authors:  L Mantovani; R L Wilder; P Casali
Journal:  J Immunol       Date:  1993-07-01       Impact factor: 5.422

4.  Characterization of monoclonal antibodies specific for equine homologues of CD3 and CD5.

Authors:  M Blanchard-Channell; P F Moore; J L Stott
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

5.  Coexpression of CD5 and CD43 predicts worse prognosis in diffuse large B-cell lymphoma.

Authors:  Xiao-Bo Ma; Yan-Ping Zhong; Yan Zheng; Jing Jiang; Yin-Ping Wang
Journal:  Cancer Med       Date:  2018-07-17       Impact factor: 4.452
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.